Experts from NYU Langone Health's Department of Neurology present their latest clinical findings and research discoveries at ...

CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine patients with advanced ovarian cancer, mesothelioma or cholangiocarcinoma ...

CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine ...

Unanticipated use of acute care soon after starting a clinical trial may predict mortality risk among older adults with metastatic cancer, according to study results.An analysis of data from several r ...

Patients with advanced platinum-resistant ovarian cancer whose disease had progressed on standard therapy experienced ...

Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...

Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation ...

Dr. Maryam Lustberg discusses the REVITALIZE trial testing CO2 laser therapy to treat vaginal dryness and GSM in breast ...

The frequency of DTH reactions increased by approximately 4x (290%) in the total open-label non-HLA-A*02 population, increasing from 5.2% of the patients experiencing a DTH reaction at baseline, prior ...

A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in ...

Authorization provides regulated capability to evaluate emerging therapeutic approaches alongside Phase 2 CALMA trial ...